HomeTOP STORIESGenentech multiple sclerosis candidate fenebrutinib meets goal in late-stage trial Genentech multiple sclerosis candidate fenebrutinib meets goal in late-stage trial By rogerjudd February 7, 2026 FacebookTwitterPinterestWhatsApp Post Content Previous articleBlock may eliminate up to 10% of positions – reportNext articleTwo teens arrested after 15-year-old shot near Washington, DC’s Union Station latest articles Industrial Logistics names Anthony Paula as chief financial officer and treasurer Moderna rallies 12% to set new high At 92, the Bard of Bollywood Is Still Writing About Love It’s Raining Boxes: Amazon Drones Overwhelm a Texas Suburb At 92, the Bard of Bollywood Is Still Writing About Love Julie Orringer Didn’t Know How Close to Home Her Novel Would Be explore more Industrial Logistics names Anthony Paula as chief financial officer and treasurer Moderna rallies 12% to set new high At 92, the Bard of Bollywood Is Still Writing About Love It’s Raining Boxes: Amazon Drones Overwhelm a Texas Suburb At 92, the Bard of Bollywood Is Still Writing About Love Julie Orringer Didn’t Know How Close to Home Her Novel Would Be